Mechanisms of protein quality control in health and disease.

Supervisor: Pedro Carvalho

The accumulation of misfolded proteins and aberrant protein aggregates is a hallmark of numerous human diseases, including neurodegenerative disorders and cancer. Under normal conditions, potentially toxic proteins are kept at low levels by sophisticated quality control systems that recognize damaged or misfolded proteins and target them for degradation. Our laboratory investigates these protein quality control pathways, with a particular focus on endoplasmic reticulum-associated degradation (ERAD), which monitors the quality of membrane and secreted proteins.

ERAD is an evolutionarily conserved pathway that regulates the turnover of thousands of proteins in mammalian cells, influencing diverse cellular processes including lipid metabolism, stress responses, cell signaling, and intercellular communication. Defects in ERAD have been linked to a wide range of human diseases, highlighting its central role in cellular homeostasis.

We study ERAD using multidisciplinary approaches in both human and yeast model systems. By combining CRISPR-based genome-wide genetic screens, advanced fluorescence microscopy, biochemistry, and structural biology, we seek to uncover the molecular mechanisms that control the recognition and degradation of disease-relevant proteins. Our work has revealed previously unrecognized roles for ERAD in maintaining endoplasmic reticulum homeostasis, organizing the nuclear envelope, and regulating lipid metabolism.

Our research is driven by fundamental biological questions while maintaining strong relevance to human health. Students joining the lab will have the opportunity to work at the interface of cell biology, genetics, biochemistry, and structural biology, contributing to discoveries that may ultimately inform new therapeutic strategies for protein-misfolding diseases.

Publications:

  • Bryant OJ, Sergejevs N, Giacomo F, Robson-Tull J, Deme JC, Forrest LR, Carvalho P, Lea SM. (2026) Dimeric architecture and membrane thinning govern substrate recognition by human signal peptide peptidase. Res Sq [Preprint] doi: 10.21203/rs.3.rs-9372626/v1.
  • Sergejevs N, Carvalho P. (2025) Mechanisms of transmembrane domain recognition during ER quality control. Curr. Opin. Cell Biol.
  • Ji Z, Siu WS, Duenas ME, Müller L, Trost M, Carvalho P. (2025) Suppression of TGF-β/SMAD signaling by an inner nuclear membrane phosphatase complex. Nat Commun. Apr 11;16(1):3474
  • Krshnan L, Siu WS, Van de Weijer M, Hayward D, Guerrero EN, Gruneberg U, Carvalho P. (2022) Regulated degradation of the inner nuclear membrane protein SUN2 maintains nuclear envelope architecture and function. eLife 10.7554/eLife.81573
  • Klug Y, Deme J, Corey R, Renne M, Stansfeld P, Lea S, Carvalho P. (2021) Mechanism of lipid droplet formation by the yeast Sei1/Ldb16 Seipin complex. Nat Commun.

Carvalho lab

Investigating the role of the ER in protein degradation and organelle biogenesis.

Available PhD Projects

Over 30 groups work at the Dunn School to uncover the molecular and cellular mechanisms underlying disease. Discover which research groups are accepting students for our next round of applications.

About our PhD course

Doing a DPhil in Molecular Cell Biology in Health and Disease at the Dunn School is the best way to start your career.